With the opioid crisis resulting in up to a 30% increase in overdoses among men and a 24% increase among women from July 2016 through September 2017, it is imperative that health care providers (HCPs), including pharmacists, work with patients to achieve goals that will reverse these destructive trends. When making treatment decisions, HCPs also need to make patients aware of safer, non-opioid alternatives to pain management.
The second installment of this CME Outfitters BriefCase series on addressing the opioid epidemic in our communities focuses on how HCPs can educate their patients about their pain and about nonopioid pain management in order to optimize safe and effective, multimodal treatment plans.
At the end of this CME/CE activity, participants should be able to:
Supported by an educational grant from Johnson & Johnson, administered by Johnson & Johnson.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Vincent Capone, MPAS, MSW, PA-C has no disclosures to report.
Peter Kreckel, RPh has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.